EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection

M Kunkel, M Doyle-Eisele, P Kuehl, K Rotermund, M Hittinger, S Ufer, M Reed, M Grant, T Hofmann iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01144-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von M Kunkel und 8 weiteren Autor:innen. Beteiligte Einrichtung: MarkAllen Consulting LLC, Lawrenceville, New Jersey, USA. Hauptthemen laut MEDLINE: Clofazimine, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary nontuberculous mycobacteria (NTM) infection is recognized as a major global health concern due to its rising prevalence worldwide. As an opportunistic pathogen with increasing antibiotics resistance, prolonged systemic dosing with multiple antibiotics remains the primary treatment paradigm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClofazimineMycobacterium Infections, NontuberculousMaleAnimalsDogsFemaleNontuberculous MycobacteriaToxicokineticsAnti-Bacterial AgentsLung

Stichwörter der Autor:innen

NTM infectionclofazimineinhalationnebulizationnontuberculous mycobateriapre-clinical

Substanzen

ClofazimineAnti-Bacterial Agents

Autor:innen und Institutionen

  • MarkAllen Consulting LLC, Lawrenceville, New Jersey, USA.
  • Lovelace Biomedical, Albuquerque, New Mexico, USA.
  • PharmBioTec Research and Development GmbH, Saarbrücken, Germany.
  • Swabian Tech LLC, Raleigh, North Carolina, USA.
  • COELUS LLC, Albuquerque, New Mexico, USA.
  • MannKind Corporation, Danbury, Connecticut, USA.

ORCID-Profile: T Hofmann

Zitieren

APA

Kunkel, M., Doyle-Eisele, M., Kuehl, P., Rotermund, K., Hittinger, M., Ufer, S., Reed, M., Grant, M., & Hofmann, T. (2023). Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01144-22

Vancouver

Kunkel M, Doyle-Eisele M, Kuehl P, Rotermund K, Hittinger M, Ufer S, et al. Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01144-22

BibTeX
@article{Kunkel2023,
  author = {Kunkel, M and Doyle-Eisele, M and Kuehl, P and Rotermund, K and Hittinger, M and Ufer, S and Reed, M and Grant, M and Hofmann, T},
  title = {Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01144-22}
}
Kostenlos starten →